Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Forman, R.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forman, R.G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 11, 2687-2688, November 1999
© 1999 European Society of Human Reproduction and Embryology

Debate continued

Severe OHSS—an acceptable price?

R.G. Forman

Centre for Reproductive Medicine, 94 Harley Street, London W1N 1AF, UK

The first 10% of the full text of this article appears below.


   Introduction
 
Burgeoning literature over the past decade has well documented the complication of severe ovarian hyperstimulation syndrome (OHSS). All clinicians involved in the management of infertile women should be expected to know the presentation and management of this serious condition. The contribution by Abramov et al. is useful as it presents a large retrospective analysis of virtually an entire country's worth of data from tertiary referral centres over a 10 year period (Abramov et al., 1999Go). However, I would disagree with several of the conclusions drawn by the authors and I would regard their data as being reassuring rather than a cause for concern. They describe an `epidemic' of OHSS. An epidemic would be defined as a . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
G. B. Inge, P. R. Brinsden, and K. T. Elder
Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful?
Hum. Reprod., March 1, 2005; 20(3): 588 - 592.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Bellver, E. A. Munoz, A. Ballesteros, S. R. Soares, E. Bosch, C. Simon, A. Pellicer, and J. Remohi
Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study
Hum. Reprod., November 1, 2003; 18(11): 2283 - 2288.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. Bellver, E. Escudero, and A. Pellicer
Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome (OHSS): Ovarian mutilating surgery is not an option in the management of severe OHSS
Hum. Reprod., July 1, 2003; 18(7): 1363 - 1367.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. Raziel, S. Friedler, M. Schachter, D. Strassburger, E. Mordechai, and R. Ron-El
Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome
Hum. Reprod., January 1, 2002; 17(1): 107 - 110.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. Kol and J. Itskovitz-Eldor
Severe OHSS: Yes, there is a strategy to prevent it!
Hum. Reprod., November 1, 2000; 15(11): 2266 - 2267.
[Abstract] [Full Text] [PDF]